1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, November 2016 (p6)

Biological Therapy Analysis & Statistics, November 2016 (p6)

24/7 Customer Support

Talk to Veronica

+44 207 0971 241

Publishers

151-180 of about 1100 reports

Purchase Reports From Reputable Market Research Publishers

Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2016

Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2016

  • € 1136
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “Fibroblast Activation Protein (FAP or Seprase) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Interleukin (IL) Inhibitors -Pipeline Insights, 2016

Interleukin (IL) Inhibitors -Pipeline Insights, 2016

  • € 1136
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “Interleukin (IL) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Interleukin (IL) Inhibitors. ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2016

  • € 1136
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2016

  • € 1136
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy
 Growth Hormone Deficiency-Pipeline Insights, 2016

Growth Hormone Deficiency-Pipeline Insights, 2016

  • € 1136
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “ Growth Hormone Deficiency-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone Deficiency. ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2016

  • € 1136
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy
 Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2016

Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2016

  • € 1136
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “ Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hematopoietic ...

  • Industries : Biological Therapy, Blood Supply, Tissue Banking and Transplantation
Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist -Pipeline Insights, 2016

Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist -Pipeline Insights, 2016

  • € 1136
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2016

  • € 1136
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor 1 (FGF-1) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast ...

  • Industries : Biological Therapy
GM-CSF Inhibitors -Pipeline Insights, 2016

GM-CSF Inhibitors -Pipeline Insights, 2016

  • € 1136
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “GM-CSF Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the GM-CSF Inhibitors. The DelveInsight’s ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2016

  • € 1136
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor (FGFR) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the ...

  • Industries : Biological Therapy
Global CRISPR/Cas9 Market Outlook 2022

Global CRISPR/Cas9 Market Outlook 2022

  • € 1091
  • Industry report
  • October 2016
  • by RNCOS

The advent of CRISPR/Cas9 has revolutionized the Genome Editing Industry. This technique is allowing a previously unattainable level of genomic targeting with greater efficiency and simplicity. Due to ...

  • Industries : Biological Therapy
  • Countries : World, North America
Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations

Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations

  • € 901
  • Industry report
  • November 2016
  • by Cancer Research Analytics

“Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations” is a comprehensive report on Neupogen and Neulasta, two market leading drugs (by ...

  • Industries : Pharmaceutical, Biotechnology, Biological Therapy, Biopharmaceutical, Drug Discovery and Development, Generic Drug, Therapy
  • Countries : Japan, Asia
Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic SWOT Analysis Review

Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic SWOT Analysis Review

  • € 273
  • Company report
  • October 2016
  • by Global Data

Summary Protalix BioTherapeutics, Inc. (Protalix) is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins. The company provides elelyso, a plant cell-expressed ...

  • Industries : Biological Therapy
International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

  • € 273
  • Company report
  • October 2016
  • by Global Data

Summary International Stem Cell Corporation (ISCC) is a biotechnology company that develops technology solutions. The company develops parthenogenesis, which is a stem cell technology that improves the ...

  • Industries : Biological Therapy
Japan Tissue Engineering Co., Ltd. (7774) - Financial and Strategic SWOT Analysis Review

Japan Tissue Engineering Co., Ltd. (7774) - Financial and Strategic SWOT Analysis Review

  • € 273
  • Company report
  • October 2016
  • by Global Data

Summary Japan Tissue Engineering Co., Ltd. (J-TEC) is a bio-venture company that develops, manufactures and sells tissue-engineered medical products and related products. The company's products include ...

  • Countries : Japan
Human Stem Cells Institute (ISKJ) - Financial and Strategic SWOT Analysis Review

Human Stem Cells Institute (ISKJ) - Financial and Strategic SWOT Analysis Review

  • € 273
  • Company report
  • October 2016
  • by Global Data

Summary Human Stem Cells Institute (HSCI) is a biotechnology company that carries out the discovery, research and development, and marketing of proprietary products and services in the areas of regenerative ...

  • Industries : Biological Therapy
Pathfinder Cell Therapy Inc (PFND) - Financial and Strategic SWOT Analysis Review

Pathfinder Cell Therapy Inc (PFND) - Financial and Strategic SWOT Analysis Review

  • € 273
  • Company report
  • October 2016
  • by Global Data

Summary Pathfinder Cell Therapy Inc (Pathfinder) is a regenerative medicine company that develops novel based therapies. The company has discovered a new mammalian cell type which is able to stimulate ...

  • Industries : Biological Therapy
Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • September 2016
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a heath biotechnology company that develops, manufactures and markets synthetic proteins. The company develops treatments for acute and chronic wound healing applications ...

  • Industries : Biological Therapy
Synergys Biotherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Synergys Biotherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • September 2016
  • by Global Data

Summary Synergys Biotherapeutics, Inc. (Synergys Biotherapeutics) is an early stage company that develops targeted antibody biotherapeutic products for treatment of various solid tumors. The company's ...

  • Industries : Biological Therapy, Cancer
  • Countries : United States
Protalix BioTherapeutics, Inc. (PLX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Protalix BioTherapeutics, Inc. (PLX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • September 2016
  • by Global Data

Summary Protalix BioTherapeutics, Inc. (Protalix) is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins. The company provides elelyso, a plant cell-expressed ...

Progenitor Cell Therapy, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Progenitor Cell Therapy, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • September 2016
  • by Global Data

Summary Progenitor Cell Therapy, LLC (PCT), a subsidiary of Caladrius Biosciences, Inc. is an external development and manufacturing company that offers cell therapy products. The company offers services ...

  • Industries : Biological Therapy
  • Countries : United States
Oxford BioTherapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oxford BioTherapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • September 2016
  • by Global Data

Summary Oxford BioTherapeutics Ltd (Oxford BioTherapeutics) is a biotechnology company that focuses on the development antibody drug conjugates (ACDs) for the treatment of wide variety of cancers. The ...

  • Industries : Biological Therapy
International Stem Cell Corporation (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

International Stem Cell Corporation (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • September 2016
  • by Global Data

Summary International Stem Cell Corporation (ISCC) is a biotechnology company that develops technology solutions. The company develops parthenogenesis, which is a stem cell technology that improves the ...

  • Industries : Biological Therapy
Japan Tissue Engineering Co., Ltd. (7774) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Japan Tissue Engineering Co., Ltd. (7774) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • September 2016
  • by Global Data

Summary Japan Tissue Engineering Co., Ltd. (J-TEC) is a pharmaceutical company that develops, manufactures and sells tissue-engineered medical products and related products. The company's products include ...

  • Industries : Pharmaceutical
  • Countries : Japan
Juvaris BioTherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Juvaris BioTherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • September 2016
  • by Global Data

Summary Juvaris BioTherapeutics, Inc. (Juvaris) is a pharmaceutical company that develops adjuvanted vaccines and immunotherapeutics to treat cancer and infectious disease in the fields of human and animal ...

  • Industries : Biological Therapy, Pharmaceutical
Harvard Stem Cell Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Harvard Stem Cell Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • September 2016
  • by Global Data

Summary Harvard Stem Cell Institute (HSCI), a part of Harvard University is a healthcare institute that conducts research on advance stem cell science using stem cell biology to develop new treatments ...

  • Industries : Healthcare
U.S. Stem Cell, Inc. (USRM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

U.S. Stem Cell, Inc. (USRM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • September 2016
  • by Global Data

Summary U.S. Stem cell, Inc., (formerly Bioheart, Inc.) is a biotechnology company which focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs ...

  • Industries : Biological Therapy
  • Countries : United States
Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

  • € 227
  • Company report
  • September 2016
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a heath biotechnology company that develops, manufactures and markets synthetic proteins. The company develops treatments for acute and chronic wound healing applications ...

  • Industries : Biological Therapy
BCMA-Targeted Antibodies & T-Cells in: October 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells

BCMA-Targeted Antibodies & T-Cells in: October 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells

  • € 200
  • Industry report
  • November 2016
  • by La Merie Publishing

BCMA-Targeted Antibodies & T-Cells in: October 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells This pdf report contains information about TCR & CAR engineered T-cells and NK cells ...

  • Industries : Biological Therapy

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.